# Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer

> **NCT02324101** · NA · UNKNOWN · sponsor: **Protgen Ltd** · enrollment: 1100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Hsp90

## Key facts

- **NCT ID:** NCT02324101
- **Lead sponsor:** Protgen Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324101, "Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02324101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*